Usefulness of measuring reticulocyte hemoglobin equivalent in the management of haemodialysis patients with iron deficiency

International Journal of Laboratory Hematology

Volumn 32, Issue 2, 2010, Pages 248-255

  Miwa, N ^a   Akiba, T ^a   Kimata, N ^a   Hamaguchi, Y ^b   Arakawa, Y ^a   Tamura, T ^a   Nitta, K ^a   Tsuchiya, K ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SYSMEX CORPORATION   (Japan)

Author keywords

Content of reticulocyte hemoglobin; Erythropoietin; Functional iron deficiency; Reticulocyte hemoglobin equivalent; ROC curve; Transferrin saturation

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; ARTICLE; AUTOANALYZER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE MARKER; ERYTHROCYTE; ERYTHROCYTE COUNT; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETICULOCYTE; RETICULOCYTE HEMOGLOBIN CONTENT; SENSITIVITY AND SPECIFICITY;

ANEMIA, IRON-DEFICIENCY; BIOLOGICAL MARKERS; HEMOGLOBINS; HUMANS; IRON; RENAL DIALYSIS; RETICULOCYTE COUNT; RETICULOCYTES; ROC CURVE;

EID: 77953554528     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2009.01179.x     Document Type: Article

References (23)

1. Brugnara C., Hipp M.J., Irving P.J., Lathrop H., Lee P.A., Minchello E.M. & Winkelman J. (1994) Automated reticulocyte counting and measurement of reticulocyte cellular indices: evaluation of the Miles H*3 blood analyzer. American Journal of Clinical Pathology 102, 623-632.
2. Brugnara C., Schiller B. & Moran J. (2006) Reticulocyte hemoglobin equivalent (RET-He) and assessment of irondeficient states. Clinical Chemistry and Laboratory Medicine 28, 303-308.
3. Cullen P., Soffker J., Hopfl M., Bremer C., Schlaghecken R., Mehrens T., Assmann G. & Schaefer R. (1999) Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrology, Dialysis, Transplantation 14, 659-665.
4. Daschner M., Mehls O. & Schaefer F. (1999) Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients. Clinical Nephrology 52, 246-252.
5. Eschbach J.W., Egrie J.C., Downing M.R., Browne J.K. & Adamson J.W. (1987) Correction of the anaemia of endstage renal disease with recombinant human erythropoietin: results of a combined phase I and II clinical trial. New England Journal of Medicine 316, 73-78.
6. Evans R.W., Rader B. & Manninen D.L. (1990) The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 263, 825-830.
7. Fishbane S. & Lynn R.I. (1995) The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients. Clinical Nephrology 44, 238-240.
8. Fishbane S., Galgano C., Langley Jr R.C., Canfield W. & Maesaka J.K. (1997) Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney International 52, 217-222.
9. Frankenfield D., Johnson C.A., Wish J.B., Rocco M.V., Madore F. & Owen W.F. (2000) Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project. Kidney International 57, 578-589. (Pubitemid 30430650)
10. Gejyo F., Saito A., Akizawa T., Akiba T., Sakai T., Suzuki M., Tsubakihara Y., Nishi S. & Hirakata H. (2004) Guideline for renal anemia in chronic hemodialysis patients. Journal of Japanese Society for Dialysis Therapy 37, 1737-1763.
11. Macdougall I.C. (1995) Poor response to erythropoietin should be fully investigated and treated. British Medical Journal 310, 1424-1425.
12. Macdougall I.C., Hutton R.D., Cavill I., Coles G.A. & Williams J.D. (1989) Poor response to treatment of renal anemia with erythropoietin corrected by iron given intravenously. British Medical Journal 299, 157-158.
13. Mittman N., Sreedhara R., Mushnick R., Chattopadhyay J., Zelmanovic D., Vaseghi M. & Avram M.M. (1997) Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. American Journal of Kidney Diseases 30, 912-922.
14. Muirhead N., Bargman J., Burgess E., Jindal K.K., Levin A., Nolin L. & Parfrey P. (1995) Evidence-based recommendations for the clinical use of recombinant human erythropoietin. American Journal of Kidney Diseases 26(2 suppl 1), S1-24.
15. National Kidney Foundation. (2006) KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. American Journal of Kidney Diseases 47(5 Suppl 3), S11-145.
16. Schaefer R.M. & Schaefer L. (1995) The hypochromic red cell: A new parameter for monitoring of iron supplementation during rHuEPO therapy. Journal of Perinatal Medicine 23, 83-88.
17. Skikne B.S., Flowers C.H. & Cook J.D. (1990) Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 75, 1870-1876.
18. Stoves J., Inglis H. & Newstead C.G. (2001) A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. Nephrology, Dialysis, Transplantation 16, 967-974.
19. Tessitore N., Solero G.P., Lippi G., Bassi A., Faccini G.B., Bedogna V., Gammaro L., Brocco G., Restivo G., Bernich P., Lupo A. & Maschio G. (2001) The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythopoietin. Nephrology, Dialysis, Transplantation 16, 1416-1423.
20. Thomas L., Franck S., Messinger M., Linssen J., Marcus Thomé M. & Thomas C. (2005) Reticulocyte hemoglobin measurement - comparison of two methods in the diagnosis of iron-restricted erythropoiesis. Clinical Chemistry and Laboratory Medicine 43, 1193-1202.
21. Tsuchiya K., Okano H., Teramura M., Iwamoto Y., Yamashita N., Suda A., Shimada K., Nihei H. & Ando M. (2003) Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients. Clinical Nephrology 59, 115-123.
22. Van Wyck D.B., Stivelman J.C., Rutz J., Kirlin L.F., Katz M.A. & Ogden D.A. (1989) Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney International 35, 712-716.
23. Wish J.B. (2006) Assessing iron status: beyond serum ferritin and transferrin saturation. Clinical Journal of the American Society of Nephrology 1, S4-8.